GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8U0T | 8U0T | PRD-0038 RBD bound to Rhinolophus alcyone ACE2 (local refinement) | |
8U01 | B5CXD3 | Crystal Structure of the Glycoside Hydrolase Family 2 TIM Barrel-domain Containing Protein from Phocaeicola plebeius | |
8TZU | P36334 | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
8TZU | 8TZU | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
8TZR | P56704 | Structure of human Wnt3a bound to WLS and CALR | |
8TZR | Q5T9L3 | Structure of human Wnt3a bound to WLS and CALR | |
8TZR | P27797 | Structure of human Wnt3a bound to WLS and CALR | |
8TZO | O00755 | Structure of human Wnt7a bound to WLS and CALR | |
8TZO | Q5T9L3 | Structure of human Wnt7a bound to WLS and CALR | |
8TZO | P27797 | Structure of human Wnt7a bound to WLS and CALR | |
8TYP | P09871 | Complement Protease C1s Inhibited by 6-(4-phenylpiperazin-1-yl)pyridine-3-carboximidamide | |
8TYO | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
8TYL | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
8TY7 | G8EHJ9 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TY7 | I1ZFF9 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TY7 | 8TY7 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TY1 | P00451 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
8TY1 | P12263 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
8TY1 | 8TY1 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
8TXT | Q5EP31 | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
8TXT | A0A6B7HQ27 | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
8TXT | 8TXT | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
8TXP | C3W5S1 | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TXP | I1ZFF9 | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TXP | 8TXP | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TXM | C3W5S1 | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TXM | A0A1D5AKA4 | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TXM | 8TXM | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
8TWO | P13835 | AvrB bound with UDP and RIN4_T166-Rha | |
8TWO | 8TWO | AvrB bound with UDP and RIN4_T166-Rha | |
8TW3 | 8TW3 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
8TW3 | H6X1Z0 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
8TVI | 8TVI | Langya Virus G glycoprotein (LayV G) with stabilizing mutations | |
8TVH | A0AA82WPF7 | Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region | |
8TVH | 8TVH | Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region | |
8TVG | 8TVG | Langya henipavirus postfusion F protein in complex with the 4G5 Fab, local refinement of the viral membrane distal region | |
8TVF | 8TVF | Langya henipavirus fusion protein in prefusion state | |
8TVE | 8TVE | Langya henipavirus fusion protein in postfusion state | |
8TVB | I0E092 | Ghanaian virus fusion glycoprotein (GhV F) | |
8TVB | Q9WXS1 | Ghanaian virus fusion glycoprotein (GhV F) | |
8TUI | P43628 | Crystal structure of Fab-Lirilumab bound to KIR2DL3 | |
8TUI | 8TUI | Crystal structure of Fab-Lirilumab bound to KIR2DL3 | |
8TUD | P0DOX5 | IgG1 Fc Heterodimer combYSelect2 | |
8TU9 | Q68CP4 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8TU9 | A0A9X4KGN5 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8TTZ | G8E2R2 | Crystal structure of monkey TLR7 ectodomain with compound 20 | |
8TTY | G8E2R2 | Crystal structure of monkey TLR7 ectodomain with compound 5 | |
8TTW | Q2N0S6 | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
8TTW | Q2N0S5 | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
8TTW | 8TTW | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024